Literature DB >> 24495267

In vivo 35Cl MR imaging in humans: a feasibility study.

Armin M Nagel1, Frank Lehmann-Horn, Marc-André Weber, Karin Jurkat-Rott, Maya B Wolf, Alexander Radbruch, Reiner Umathum, Wolfhard Semmler.   

Abstract

PURPOSE: To implement chlorine 35 ((35)Cl) magnetic resonance (MR) at a 7-T whole-body MR system and evaluate its feasibility for imaging humans.
MATERIALS AND METHODS: All examinations were performed with ethical review board approval; written informed consent was obtained from all volunteers. Seven examinations each of brain and muscle in healthy volunteers and four examinations of patients were performed. Two patients with histologically confirmed glioblastoma multiforme underwent brain imaging. (35)Cl MR and (35)Cl inversion-recovery (IR) MR were performed. Two patients with genetically confirmed hypokalemic periodic paralysis underwent calf muscle imaging. Seven multiecho sequences (acquisition time, 5 minutes; voxel dimension, 11 mm(3)) were applied to determine transverse relaxation time as affected by magnetic field heterogeneity (T2*) and chlorine concentration. (35)Cl and sodium 23 ((23)Na) MR were conducted with a 7-T whole-body MR system. (35)Cl longitudinal relaxation time (T1) and T2* of healthy human brain and muscle were determined with a three-dimensional density-adapted-projection reconstruction technique to achieve short echo times and high signal-to-noise ratio (SNR) efficiency. A nonlinear least squares routine and mono- (T1) and biexponential (T2*) models were used for curve fitting.
RESULTS: Phantom imaging revealed 15-fold lower SNR and much shorter relaxation times for (35)Cl than (23)Na. In vivo T2* was biexponential and extremely short. Monoexponential fits of T1 revealed 9.2 and 4.0 milliseconds ± 0.7 (standard deviation) for brain and muscle, respectively. In glioblastoma tissue, increased Cl(-) concentrations and increased Cl(-) IR signal intensities were detected. Voxel dimension and acquisition time, respectively, were 6 mm(3) and 9 minutes 45 seconds ((35)Cl MR) and 10 mm(3) and 10 minutes ((35)Cl IR MR). In patients with hypokalemic periodic paralysis versus healthy volunteers, Cl(-) and Na(+) concentrations were increased. Cl(-) concentration of muscle could be determined (voxel size, 11 mm(3); total acquisition time, 35 minutes).
CONCLUSION: MR at 7 T enables in vivo imaging of (35)Cl in human brain and muscle in clinically feasible acquisition times (10-35 minutes) and voxel volumes (0.2-1.3 cm(3)). Pathophysiological changes of Cl(-) homeostasis due to cancer or muscular ion channel disease can be visualized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24495267     DOI: 10.1148/radiol.13131725

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

Review 1.  [Functional MRI 2.0. ²³Na and CEST imaging].

Authors:  S Haneder; S Konstandin
Journal:  Radiologe       Date:  2016-02       Impact factor: 0.635

2.  [Towards more precision in the therapy of brain tumors. Possibilities and limits of MRI].

Authors:  A Radbruch; E Hattingen
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

3.  Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond.

Authors:  Lukas Winter; Thoralf Niendorf
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

Review 4.  Ultra-High-Field MR Neuroimaging.

Authors:  P Balchandani; T P Naidich
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

5.  Improved T*₂ determination in 23Na, 35Cl, and 17O MRI using iterative partial volume correction based on 1H MRI segmentation.

Authors:  Sebastian C Niesporek; Reiner Umathum; Thomas M Fiedler; Peter Bachert; Mark E Ladd; Armin M Nagel
Journal:  MAGMA       Date:  2017-05-26       Impact factor: 2.310

Review 6.  Toward 20 T magnetic resonance for human brain studies: opportunities for discovery and neuroscience rationale.

Authors:  Thomas F Budinger; Mark D Bird; Lucio Frydman; Joanna R Long; Thomas H Mareci; William D Rooney; Bruce Rosen; John F Schenck; Victor D Schepkin; A Dean Sherry; Daniel K Sodickson; Charles S Springer; Keith R Thulborn; Kamil Uğurbil; Lawrence L Wald
Journal:  MAGMA       Date:  2016-05-18       Impact factor: 2.310

Review 7.  Advanced MR Imaging in Neuro-oncology.

Authors:  A Radbruch; M Bendszus
Journal:  Clin Neuroradiol       Date:  2015-07-29       Impact factor: 3.649

8.  High field parahydrogen induced polarization of succinate and phospholactate.

Authors:  Stephan Berner; Andreas B Schmidt; Frowin Ellermann; Sergey Korchak; Eduard Y Chekmenev; Stefan Glöggler; Dominik von Elverfeldt; Jürgen Hennig; Jan-Bernd Hövener
Journal:  Phys Chem Chem Phys       Date:  2021-01-28       Impact factor: 3.676

9.  Ultra-High-Field MRI in the Diagnosis and Management of Gliomas: A Systematic Review.

Authors:  Annabelle Shaffer; Susanna S Kwok; Anant Naik; Aaron T Anderson; Fan Lam; Tracey Wszalek; Paul M Arnold; Wael Hassaneen
Journal:  Front Neurol       Date:  2022-04-05       Impact factor: 4.003

Review 10.  Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Authors:  William D Watson; Jack J J Miller; Andrew Lewis; Stefan Neubauer; Damian Tyler; Oliver J Rider; Ladislav Valkovič
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.